Why Stealth BioTherapeutics Corp (MITO) stock is soaring in Pre-Market today?
Stealth BioTherapeutics Corp (MITO) presented the data at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Virtual Annual Meeting, which is collected in Phase 1 ReCLAIM study to evaluate elamipretide in patients having non-central geographic atrophy as well as high-risk drusen due to high dry age-related macular degeneration(AMD), after which the MITO stock […]
